Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

S&P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say

Published 03/07/2024, 07:09 PM
Updated 03/07/2024, 07:10 PM
© Reuters. FILE PHOTO: The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo
PFE
-
MS
-
PNC
-

By Suzanne McGee and Tatiana Bautzer

(Reuters) - An error by S&P Dow Jones Indices may have contributed to volatility in shares of Morgan Stanley, Pfizer (NYSE:PFE), PNC Financial Services Group (NYSE:PNC) and other stocks in recent days, traders said.

At issue was a list of pending changes to the Dow Jones U.S. Dividend 100 Index that S&P Dow Jones Indices released late on March 1, naming 10 companies slated for addition to the index and two for deletion. The changes were to take effect on March 18.

A total of 23 stocks were affected by the changes, according to trading desk notes obtained by Reuters.

A S&P spokeperson said an unspecified error led to the wrong names being provided to clients.

S&P Dow Jones issued a replacement pro forma list with a total of 11 additions and three deletions after the market's close on Tuesday.

Morgan Stanley and PNC were among the companies that were to be added to the index on the original list.

Their shares rose on Monday, but gave back those gains on Wednesday. By contrast, shares of Pfizer, which were slated for deletion on the initial list, fell on Monday but rose on Wednesday when the revisions were published and it was clear that it would remain in the index.

Trading volumes for all three companies were 50% to 80% higher than their 90-day averages this week.

Morgan Stanley and PNC declined to comment. Pfizer did not immediately respond to a request for comment.

"This is not that common an occurrence," said Bryan Armour, an analyst at Morningstar who tracks exchange-traded funds.

The error triggered a scramble on trading desks to help their own clients unwind trades made in anticipation of what proved to be incorrect upcoming changes, traders said.

© Reuters. FILE PHOTO: The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo

The Dow Jones U.S. Dividend 100 Index is designed to offer investors a benchmark composed of stocks in companies with strong fundamentals and a record of paying high dividends consistently. It is used by some index funds to build portfolios.

Some traders also seek to buy on announcements of upcoming changes before they take effect and any asset management firms using it as a benchmark must adjust their own portfolios.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.